Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Biomarker Discovery & Validation: Page 2
Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers
By
Matt Limb
The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.
July 27, 2023
Physicians advocate for ‘careful’ use of osteoporosis bone turnover marker testing
By
Nick Paul Taylor
Knowing the rate of bone matrix removal or deposition can help physicians understand if a patient is at risk of fractures or is responding to treatment.
July 24, 2023
Quest launches biomarker test to improve grading of prostate cancer biopsies
By
Nick Paul Taylor
Building on the Australian research and working with Envision Sciences, the Australian diagnostics company that owns the biomarker intellectual property, Quest’s subspecialty pathology business, AmeriPath, has developed a tissue-based test.
July 17, 2023
DiamiR Biosciences partners with JADBio on diagnostic tests, validation for biomarker panels
By
Matt Limb
Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform.
July 12, 2023
Intus Bio buys Pattern Genomics to enhance microbiome analysis capabilities
By
Nick Paul Taylor
Intus Bio sees the integration enhancing the platform with machine-learning tools for biomarker discovery and patient stratification, supporting the firm’s work in turning microbiome technologies into practical medical and pharmaceutical applications.
June 29, 2023
Nucleai, Mayo Clinic partner on digital pathology
By
LabPulse.com staff writers
The collaboration combines Nucleai’s AI-enabled spatial biology technology with Mayo’s longitudinally annotated, multimodal data sets, lab services, and clinical diagnostic footprint.
June 5, 2023
Blood biomarker in study predicts whether the cognitively healthy will develop Alzheimer’s
By
LabPulse.com staff writers
Astrocytes -- a subtype of glial cells that make up most cells in the human central nervous system -- may be the key driver of Alzheimer's disease progression, researchers said.
May 30, 2023
Biomarkers may predict stem cell transplant risks
By
Elissa Wolfson
A biomarker for donor stem cell transplant risk may help doctors predict which patients will develop potentially deadly sinusoidal obstruction syndrome.
May 23, 2023
Biomarker predicts response to chemo-immunotherapy in lung cancer patients
By
Nick Paul Taylor
Researchers see a correlation between CX3CR1 expression and outcomes in NSCLC patients treated with chemo-immunotherapy.
May 15, 2023
Hallmark Parkinson’s disease protein may aid early detection
By
Elissa Wolfson
Identifying hallmark Parkinson’s disease misfolded protein deposits could aid early detection and pave the way for improved diagnosis and treatment.
April 12, 2023
Simple blood test can detect PTSD biomarkers
By
Elissa Wolfson
People at risk or suffering from post-traumatic stress disorder show specific patterns in four biomarkers measurable with a simple blood test.
March 28, 2023
AriBio, Fujirebio partner on biomarker development for Alzheimer’s, other neurodegenerative disorders
By
LabPulse.com staff writers
The agreement will provide Fujirebio access to clinical samples and data that have been collected in an ongoing phase III Alzheimer’s disease study being conducted by AriBio.
March 8, 2023
Previous Page
Page 2 of 5
Next Page